Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fenske

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Telemedicine and Telecare|September 7, 2000
Remote cardiac rehabilitationI Henderson, K vanLohuizen, T Fenske
The American Journal of Gastroenterology|June 13, 1998
A prospective, controlled study of Helicobacter pylori seroprevalence in coronary artery diseaseA Khurshid, T Fenske, T Bajwa, et al.
Bone Marrow Transplantation|September 6, 2016
Impact of haploidentical hematopoietic cell transplantation conditioning intensity on the incidence and severity of post-transplantation viral infectionsR V Raj, P Hari, M Pasquini, et al.
Bone Marrow Transplantation|January 27, 2015
Superior efficacy but higher cost of plerixafor and abbreviated-course G-CSF for mobilizing hematopoietic progenitor cells (HPC) in AL amyloidosisB Dhakal, A D'Souza, C Arce-Lara, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Telemedicine and Telecare|September 7, 2000
Remote cardiac rehabilitationI Henderson, K vanLohuizen, T Fenske
The American Journal of Gastroenterology|June 13, 1998
A prospective, controlled study of Helicobacter pylori seroprevalence in coronary artery diseaseA Khurshid, T Fenske, T Bajwa, et al.
Bone Marrow Transplantation|September 6, 2016
Impact of haploidentical hematopoietic cell transplantation conditioning intensity on the incidence and severity of post-transplantation viral infectionsR V Raj, P Hari, M Pasquini, et al.
Bone Marrow Transplantation|January 27, 2015
Superior efficacy but higher cost of plerixafor and abbreviated-course G-CSF for mobilizing hematopoietic progenitor cells (HPC) in AL amyloidosisB Dhakal, A D'Souza, C Arce-Lara, et al.
Pageof 1